Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference22 articles.
1. Prognostic significance of cutaneous adverse events associated with pembrolizumab therapy;Lo;JAMA Oncol,2015
2. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations;Gong;J Immunother Cancer,2018
3. Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial;Long;Lancet Oncol,2017
4. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial;Ribas;Lancet Oncol,2015
5. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol,2015
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immune Checkpoint Inhibitor-Induced Psoriasis;Dermatologic Clinics;2024-07
2. Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level;JAAD International;2024-06
3. Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors;Anais Brasileiros de Dermatologia;2024-05
4. Cutaneous Side Effects of Chemotherapy and Radiotherapy;Rook's Textbook of Dermatology;2024-03-19
5. Cutaneous immune-related adverse events: incidence rates, risk factors and association with extracutaneous toxicity – a prospective study of 189 patients treated with checkpoint inhibitors at a Spanish tertiary care hospital;Clinical and Experimental Dermatology;2024-02-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3